Clinical Trial Update: Study of FK778 in Renal Transplant Recipients With Untreated BK Nephropathy [Phase 2]

View source ↗

Summary

Phase 2 trial of FK778 in renal transplant recipients with untreated BK polyomavirus nephropathy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bk Polyomavirus Nephropathy
• Chronic Kidney Disease

Drugs mentioned

• FK778

Snippet

Sponsor: Astellas Pharma Inc | Conditions: BK Polyomavirus, Kidney Diseases | Phase 2 | Status: TERMINATED